PRUEBA DE DIAGNÓSTICO IN VITRO PARA GENOTIPADO DE LA MUTACIÓN G20210A DEL GEN DEL FACTOR II (PROTROMBINA) HUMANO Y LA MUTACIÓN DEL GEN DEL FACTOR V LEIDEN HUMANO
Mexico·Clase I·III. Agentes de
diagnóstico·PRODUCTOS ROCHE, S.A.
DE C.V.·Registered February 13, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- COBAS ® FACTOR II AND FACTOR V TEST
- Trade Name (English)
- COBAS ® FACTOR II AND FACTOR V TEST
- Analysis ID
- 0502R2024 SSA
- Registration Date
- February 13, 2024
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA DE DIAGNÓSTICO IN VITRO PARA GENOTIPADO DE LA MUTACIÓN G20210A DEL GEN DEL FACTOR II (PROTROMBINA) HUMANO Y LA MUTACIÓN DEL GEN DEL FACTOR V LEIDEN HUMANO (PRUEBA DE DIAGNÓSTICO IN VITRO PARA GENOTIPADO DE LA MUTACIÓN G20210A DEL GEN DEL FACTOR II (PROTROMBINA) HUMANO Y LA MUTACIÓN DEL GEN DEL FACTOR V LEIDEN HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0502R2024 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on February 13, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.